Paper · 6444967

Biochemical characterization of lymphocyte regulatory molecules. II. Purification of a class of rat and human lymphokines.

Gillis S and 2 others. J Immunol, 1980. Cited by 278 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Biochemical characterization of lymphocyte regulatory molecules. II. Purification of a class of rat and human lymphokines. Papers, record 6444967. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6444967

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Biochemical characterization of lymphocyte regulatory molecules. II. Purification of a class of rat and human lymphokines.; PubMed
Journal: J Immunol; PubMed
Year: 1980; PubMed
Publication types: Journal Article, Research Support, U.S. Gov't, P.H.S.; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/6444967/; PubMed
The journal: https://conductscience.org/library/journal-index/2985117R; PubMed
Citations, by iCite: 278; iCite
Relative citation ratio, by iCite: 7.19; iCite
Revised in PubMed: 2008-11-21; PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Gillis S	S
2	Smith KA	K A
3	Watson J	J

Source PubMed

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Lymphocytes	Major topic
Lymphokines	Major topic
Animals
Cell Differentiation
Cell Transformation, Neoplastic
Chemical Phenomena
Chemistry
Chromatography, Gel
Chromatography, Ion Exchange
Growth Substances
Humans
Isoelectric Focusing
Lymphocyte Culture Test, Mixed
Mice
Molecular Weight
Rats
Rats, Inbred Lew
Species Specificity
Spleen
T-Lymphocytes

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by52

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 278 citations.

PMID	Title	Journal	Year	In Papers	Source
27,089,941	Mitogen-activated Tasmanian devil blood mononuclear cells kill devil facial tumour disease cells.	Immunol Cell Biol	2016	https://conductscience.org/library/papers/27089941	PubMed
9,539,645	Flow cytometric method to detect lymphocyte transformation in drug-allergic hepatic injury.	Dig Dis Sci	1998	https://conductscience.org/library/papers/9539645	PubMed
9,439,760	Protein kinase C in IL-2 signal transduction.	Immunol Res	1997	https://conductscience.org/library/papers/9439760	PubMed
7,203,558	Activation of natural killer (NK) cells in vivo with H-2 and non-H-2 alloantigens.	Immunogenetics	1981	https://conductscience.org/library/papers/7203558	PubMed
6,982,303	Correlated expression of T cell growth factor dependence, sensitivity to Vicia villosa lectin, and cytolytic activity in hybrids between cytolytic T cells and T lymphomas.	J Exp Med	1982	https://conductscience.org/library/papers/6982303	PubMed
6,980,256	Purification of human interleukin 2 to apparent homogeneity and its molecular heterogeneity.	J Exp Med	1982	https://conductscience.org/library/papers/6980256	PubMed
6,979,751	Purification and initial characterization of rat interleukin 2.	Proc Natl Acad Sci U S A	1982	https://conductscience.org/library/papers/6979751	PubMed
6,977,616	Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2.	J Exp Med	1982	https://conductscience.org/library/papers/6977616	PubMed
6,975,347	T cell growth factor receptors. Quantitation, specificity, and biological relevance.	J Exp Med	1981	https://conductscience.org/library/papers/6975347	PubMed
6,973,604	Purification of murine T cell growth factor. A lymphocyte mitogen with helper activity.	J Exp Med	1981	https://conductscience.org/library/papers/6973604	PubMed

1 to 10 of 52

See all 52 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6444967

GET https://conductscience.org/api/papers/v1/6444967/cited_by?page=2

API reference For AI assistants